Oxford Cannabinoid Technologies 'Ready To Go' After Phase 1 Trial Submission
(MENAFN- News Direct) London, UK | January 06, 2023 04:58 AM Eastern Standard Time
Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) chief scientific officer Dr Valentino Parravicini speaks to Proactive after submitting a phase 1 trial application for its lead programme (OCT461201) to the UK Medicines & Healthcare products Regulatory Agency (MHRA) and Wales Research Ethics Committee (REC). Parravicini says that the submission demonstrates that the company is 'ready to go' in 2023.
MENAFN06012023005728012573ID1105394083
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.